MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by the accumulation of amyloid-beta (Aβ) peptides and phosphorylated tau in the medial temporal lobe and neocortical structures, in addition to neuroinflammation and oxidative stress [144].